- $136.42m
- $131.99m
- $131.19m
- 57
- 73
- 20
- 48
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46.9 | 59.9 | 71.5 | 130 | 131 |
Cost of Revenue | |||||
Gross Profit | 26.3 | 26.9 | 33 | 55.6 | 56.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 47.4 | 70.4 | 74.8 | 135 | 138 |
Operating Profit | -0.488 | -10.5 | -3.34 | -5.78 | -6.67 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.267 | -10.6 | -3.85 | -7.19 | -8.23 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.408 | -10.7 | -4.04 | -5.36 | -8.98 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.408 | -10.7 | -4.04 | -5.36 | -8.98 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.408 | -10.7 | -4.04 | -5.36 | -8.98 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.036 | -0.267 | -0.115 | -0.115 | -0.23 |